Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Hybrid Tunnel May Guide Severed Nerves to Rejoin

By HospiMedica International staff writers
Posted on 26 Dec 2012
A biologic tunnel made of both hard and soft materials could guide the reconnection of severed nerve endings, helping nerve trauma patients regain feeling and movement.

Researchers at Pennsylvania State University (Penn State; University Park, USA) developed a novel hybrid conduit that consisted of agarose (a soft hydrogel) as an external wall, along with an internal wall made of an electrically-active conducting polymer to serve as a tunnel that guides the regrowth and reconnection of the severed nerve endings. More...
Since the hydrogel is permeable and expands in water and fluids, the expansion would collapse the tunnel and reduce the ability of the nerve endings to regenerate and connect.

To avoid tunnel collapse, the researchers added a conducting polymer, poly(3,4-ethylenedioxythiophene) (PEDOT) to the design to form a wall that can mechanically support and reinforce the hydrogel. PEDOT is a stable material that can conduct electricity to help electrical signals pass through the nerve. To make sure nutrients and oxygen would reach the regenerating nerve endings, the team created a spiral PEDOT design that maintained the structural integrity of the wall, but allowed some nutrients and air to reach the nerve. The study was published in the November 2012 issue of Advanced Healthcare Materials.

“Autografts are currently the gold standard for bridging nerve gaps. This is an operation that takes the nerve from another portion of the body-for instance-from a tendon, and then it is grafted onto the injured nerve,” said lead author Mohammad Reza Abidian, PhD, an assistant professor of biomedical engineering. “However, the operation can be painful and there are often mismatches in size between the severed nerve endings and the new grafted portion of the nerve.”

The researchers also tested the three designs--plain hydrogel, hydrogel with fully-coated PEDOT wall, and hydrogel with a partially coated PEDOT wall--by implanting the device in 10 mm nerve gaps in rats and measuring the muscle mass and strength of muscle contractions at the end of the nerves. These measurements can indicate whether the separated nerve has reconnected. They found that the spiral PEDOT design generated significantly more muscle mass than the other designs, although it did not generate as much muscle mass as an autograft, which was used as the control design in the study.

Related Links:

Pennsylvania State University



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.